Novo Nordisk A/S ADR (NY: NVO )

106.80 +0.67 (+0.63%)
Official Closing Price Updated: 5:00 PM EST, Nov 29, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
April 01, 2009
Form 6-K
Source: SEC/Edgar
March 31, 2009
Form 6-K
Source: SEC/Edgar
March 30, 2009
Form 6-K
Source: SEC/Edgar
March 23, 2009
Form 6-K
Source: SEC/Edgar
March 22, 2009
Form 6-K
Source: SEC/Edgar
March 22, 2009
Form 6-K
Source: SEC/Edgar
March 16, 2009
Form 6-K
Source: SEC/Edgar
March 16, 2009
Form 6-K
Source: SEC/Edgar
March 02, 2009
Form 6-K
Source: SEC/Edgar
February 24, 2009
Form 6-K
Source: SEC/Edgar
February 22, 2009
Form 6-K
Source: SEC/Edgar
February 16, 2009
Form 6-K
Source: SEC/Edgar
February 12, 2009
Form S-8 POS
Source: SEC/Edgar
February 11, 2009
Form SC 13G/A
Source: SEC/Edgar
February 11, 2009
Form 6-K
Source: SEC/Edgar
February 09, 2009
Form 6-K
Source: SEC/Edgar
February 09, 2009
Form 6-K
Source: SEC/Edgar
February 09, 2009
Form 20-F
Source: SEC/Edgar
February 08, 2009
Form 6-K
Source: SEC/Edgar
February 08, 2009
Form 6-K
Source: SEC/Edgar
February 05, 2009
Form 6-K
Source: SEC/Edgar
February 04, 2009
Form 6-K
Source: SEC/Edgar
February 01, 2009
Form 6-K
Source: SEC/Edgar
January 28, 2009
Form 6-K
Source: SEC/Edgar
January 05, 2009
Form 6-K
Source: SEC/Edgar
December 21, 2008
Form 6-K
Source: SEC/Edgar
December 15, 2008
Form 6-K
Source: SEC/Edgar
December 08, 2008
Form 6-K
Source: SEC/Edgar
December 04, 2008
Form 6-K
Source: SEC/Edgar
December 01, 2008
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.